Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Equity Average: 2013-2025

Historic Equity Average for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $54.6 million.

  • Fortress Biotech's Equity Average rose 499.14% to $54.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.6 million, marking a year-over-year increase of 499.14%. This contributed to the annual value of $22.6 million for FY2024, which is 37.60% down from last year.
  • Latest data reveals that Fortress Biotech reported Equity Average of $54.6 million as of Q3 2025, which was up 42.79% from $38.2 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Equity Average peaked at $246.3 million during Q2 2021, and registered a low of -$14.6 million during Q3 2023.
  • Its 3-year average for Equity Average is $12.6 million, with a median of $5.0 million in 2024.
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 579.81% in 2024, then spiked by 512.25% in 2025.
  • Quarterly analysis of 5 years shows Fortress Biotech's Equity Average stood at $219.2 million in 2021, then tumbled by 65.47% to $75.7 million in 2022, then slumped by 93.86% to $4.7 million in 2023, then rose by 7.50% to $5.0 million in 2024, then skyrocketed by 499.14% to $54.6 million in 2025.
  • Its Equity Average was $54.6 million in Q3 2025, compared to $38.2 million in Q2 2025 and $27.6 million in Q1 2025.